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The regulation of early B cell development and the interaction of hematopoietic precursors with stromal
cells in the bone marrow (BM) are controlled by various secreted signaling molecules. Several recent
studies showed Wnt signaling involved in B-lymphogenesis through stromal cells. However, the mole-
cules modulated by Wnt signaling in stromal cells regulating B-lymphogenesis have not been identiﬁed
yet. Interleukin (IL)-7 and CXC chemokine ligand (CXCL) 12 are known to be express in stromal cells, and
both molecules are essential for B-lymphogenesis. In the present study, we examined the role of Wnt
signaling in regulating IL-7 and CXCL12 expression and in affecting B-lymphogenesis. In mouse stromal
ST2 cells, expression of IL-7 and CXCL12 mRNA was augmented by noncanonical Wnt5a. When mouse
BM-derived cells were cultured on Wnt5a-overexpressing ST2 cells, an increased number of B220þ/IgM-
B-lymphoid precursor cells was observed. These results show that Wnt5a regulates IL-7 gene expression
in stromal cells and suggest the possibility that noncanonical Wnt regulates B-lymphogenesis via IL-7
expression in stromal cells.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
B cells are generated from hematopoietic stem cells (HSCs) in
the bone marrow (BM) after birth, and they migrate into the blood
to reach secondary lymphoid tissues, such as the spleen and
lymph nodes in mammals. The early development of B cells in the
BM is dependent on supportive microenvironment consisting of
stromal cells known as niches that maintain blood cells and supply
factors for their development [1,2]. Regulation of early B cell de-
velopment and stromal interactions of hematopoietic precursors
are thought to be controlled by various secreted signaling mole-
cules, particularly, cytokines, chemokines, and growth factors [3].
Wnt secreted proteins are powerful regulators of embryonic
development, cell differentiation, and proliferation [4,5], and they
can activate two pathways: the β-catenin-dependent canonical
and the β-catenin-independent noncanonical pathway. Non-
canonical Wnt ligands activate the Wnt/Ca2þ pathway and Wnt/
planar cell polarity (PCP) pathway [6]. It has been reported that
receptor tyrosine kinase-like orphan receptor 2 (Ror2), a member
of the Ror-family of receptor tyrosine-protein kinases, acts as a
receptor or coreceptor for Wnt5a [7]. Ror2 by itself or in combi-
nation with Frizzled protein through its Frizzled-like cysteine-richB.V. This is an open access article u
istry and Molecular Biology,
sity, North13 West7, Kita-ku,
ato).domain mediates diverse Wnt5a signaling by activating the Wnt–
c-Jun N-terminal kinase PCP pathway [8].
Several studies have shown that Wnt signaling pathway is in-
volved in the regulation of B-lymphogenesis in the hematopoietic
microenvironment, the BM [9]. Canonical Wnt3a-stimulated
stromal cells negatively regulated hematopoiesis, including early
B-lymphogenesis. In contrast, noncanonical Wnt5a-producing
stromal cells enhanced B-lymphopogenesis in culture [10,11].
However, the molecules modulated by the Wnt signaling in stro-
mal cells and involved in early B-lymphogenesis have not been
characterized yet.
Interleukin (IL)-7 and CXC chemokine ligand (CXCL) 12 (stromal
cell-derived factor-1/pre-B-cell-growth-stimulating factor), which
are supplied by stromal cells, are well known to play crucial and
essential roles in B-lymphogenesis [12,13]. Both molecules were
identiﬁed and characterized by in vitro coculture system using
several stromal cell lines, such as ST2 and PA6 cells [14]. The in vivo
studies using mutant mice with targeted gene disruption have
revealed that CXCL12 and IL-7 expression on stromal cells are
essential for B-lymphogenesis [15]. Also, IL-7 and IL-7 receptor α-
chain (IL-7Rα)–deﬁcient mice revealed impaired Bcell develop-
ment due to early B-cell progenitors [16,17]. To date, little is
known on the regulation of IL-7 production, especially in stromal
cells that are considered the main source of this cytokine.
Several growth factors and cytokines are known to modulate
B-lymphogenesis via the regulation of IL-7 and CXCL12 expression
on stromal cells. Tang et al. [18] showed that transforming growthnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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inhibits proliferation of Bcell precursors [18]. Also, TGF-β1 down-
regulates CXCL12 expression in the stromal cell line MS-5 [19].
Mice deﬁcient of G protein α subunit (GSα), which is a major
downstream activator of the parathyroid hormone- related pep-
tide receptor signaling in osterix-expressing stromal cells, speci-
ﬁcally showed a failure of B-lymphopogenesis through the re-
duction of IL-7 production in stromal cells [20]. Our previous study
demonstrated that canonical Wnt3a regulates CXCL12 expression
in ST2 cells [21]. However, the role of Wnt signaling in the reg-
ulation of IL-7 expression in stromal cells and in the development
of B cells remains unclear.
In this study, we examined the effects of Wnt signaling on the
regulation of IL-7 expression in ST2 cells, and then on B-lympho-
genesis using an in vitro coculture system. Wnt5a enhanced IL-7
expression in ST2 cells and increased the number of Bcell pro-
genitors. These ﬁndings demonstrate that noncanonical Wnt sig-
naling in stromal cells regulates B-lymphogenesis partially
through IL-7 expression.2. Materials and methods
2.1. Murine BM cells
Murine adherent cell-depleted BM cells were isolated from
seven-week-old C57BL/6J mice from Nippon Clea (Tokyo, Japan).
The experiments were performed in accordance with the guide-
lines on the care and use of laboratory animals and have been
approved by Hokkaido University.
2.2. Cell cultures
ST2 cells were obtained as described previously [21]. Wnt3a-
ST2 and Wnt5a-ST2 cells were established as described previously
[21]. Cells were grown to semiconﬂuence in alpha minimum es-
sential medium (α-MEM) (Sigma-Aldrich, St. Louis, MO, USA)
containing 100 μg/mL kanamycin (Meiji, Tokyo, Japan) and sup-
plemented with 10% fetal bovine serum (FBS; PAA Laboratories;
Pasching, Austria) at 37 °C (Corning, Corning, NY, USA) in a hu-
midiﬁed atmosphere of 5% CO2. The medium was removed, and
1106 adherent cell-depleted BM cells were cultured with or
without ST2, Wnte3a-ST2, or Wnt5a-ST2 cell layer in RPMI1640
medium (Sigma-Aldrich) supplemented with 5% FBS and 50 μM
2-mercaptoethanol at 37 °C for 4, 5, or 7 days. Floating cells were
analyzed by ﬂow cytometry.
2.3. Reagents
Mouse recombinant Wnt5a was obtained from R&D Systems
Inc. (Minneapolis, MN, USA).
2.4. Flow cytometry
Flow cytometry analysis was carried out using the following
antibodies: PE-anti-B220, PE-anti-CD3ε and PE-anti-CD11b from
BD Bioscience (BD Bioscience, San Jose, CA). Stained cells were
analyzed for surface expression using a ﬂow cytometer (FACSCa-
libur; BD Biosciences) and analyzed with CellQuest software (BD
Biosciences) as described previously [22].
2.5. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from the cells using Isogen (Nippon-
gene, Toyama, Japan), and RT-PCR was performed as previously
described [23]. All the primers were synthesized by HokkaidoSystem Science (Sapporo, Japan). The primer sequences were de-
scribed previously [24].
2.6. Quantiﬁcation of gene expression by quantitative RT-PCR (qRT-
PCR)
Total RNA was reverse transcribed using ﬁrst-strand cDNA
synthesis with random primers (Promega, Madison, WI, USA). The
PCR was performed using SYBER Green (Invitrogen Life Technol-
ogies Carlsbad, CA, USA) and ABI StepOne Plus real-time PCR
system (Applied Biosystems, Foster City, CA, USA). Primer se-
quences for each gene were the following: CXCL12,　5′-CAA-
CACTCCAAACTGTGCCCTTCA-3′ (forward), 5′-TCCTTTGGGCTGTTG
TGCTTACT-3′ (reverse); IL-7, 5′-TGGGAGTGATTATGGGTGGT-3′
(forward), 5′-GCGAGCAGCACGATTTAGAAAAGC-3′ (reverse); thy-
mic stromal lymphopoietin (TSLP), 5′-AGGCTACCCTGAAACTGAG-3′
(forward), 5′-GGAGATTGCATGAAGGAATACC-3′ (reverse); β-actin;
5′-CTTCTTTGCAGCTCCTTCGTTG-3′ (forward), 5′-CGACCAGCG-
CAGCGATATC-3′ (reverse). The relative level of gene expression
was quantiﬁed using the comparative Ct method with β-actin as
the endogenous control.
2.7. Cell proliferation assay
To quantify cell proliferation, the tetrazolium-based colori-
metric CCK-8 assay (Dojindo Laboratories, Kumamoto, Japan) was
used. A 20 mL aliquot of the substrate WST-8 (2-[2-methoxy-4-
nitrophenyl]-3-[4-nitrophenyl]-5-[2,4-disulfophenyl]-2H-tetra-
zolium, monosodium salt) was added to each well. After incuba-
tion for 2 h at 37 °C, the optical density was measured at a wa-
velength of 450 nm using a microplate reader (iMark, Bio-Rad
Laboratories, Richmond, CA, USA).
2.8. Statistical analysis
All experiments were repeated three to four times and re-
presentative results are shown. The data are reported as the
mean7standard deviation (SD) and were analyzed by Student's t-
test, where p values o0.05 were considered signiﬁcant.3. Results
3.1. Wnt signaling regulates IL-7 and CXCL12 expression in ST2 cells
To evaluate the role of Wnt signaling on IL-7 and CXCL12 reg-
ulation, which is essential for B-lymphogenesis in stromal cells, we
examined their mRNA expression using qRT-PCR. We had pre-
viously established stromal ST2 cells expressing either Wnt3a
(Wnt3a-ST2 cells), which stimulates canonical Wnt signaling, or
Wnt5a (Wnt5a-ST2 cells), which stimulates noncanonical Wnt
signaling [21]. IL-7 mRNA expression level was upregulated in
both Wnt3a-ST2 and Wnt5a-ST2 cells, particularly in Wnt5a-ST2
cells, compared with vehicle-transfected ST2 cells (Fig. 1A).
CXCL12 mRNA level was increased in Wnt5a-ST2 cells, whereas it
was reduced in Wnt3a-ST2 cells. However, mRNA expression of
the IL-7-related cytokine TSLP, the receptor formed by a hetero-
dimer of IL-7Rα and another receptor subunit, was altered neither
by Wnt3a nor by Wnt5a overexpression in ST2 cells (Fig. 1A).
Treatment with the recombinant Wnt5a protein (200 ng/mL) also
signiﬁcantly increased IL-7 mRNA expression in ST2 cells (Fig. 1B).
To conﬁrm the increment of IL-7 mRNA expression by Wnt5a in
another cell line, we examined Wnt5a-C2C12 cells, previously
established [23]. In Wnt5a-C2C12 cells, IL-7 mRNA expression le-
vel was 1.75 times higher than that in C2C12 cells (data not
shown; relative average value, n¼6). These results indicate that
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Fig. 1. Noncanonical Wnt signaling modulates interleukin (IL)-7 gene expression in
ST2 cells. (A) ST2, Wnt3a-ST2, or Wnt5a-ST2 cells were cultured to semiconﬂuence,
and total RNA was extracted. IL-7 (left), CXCL12 (center), and thymic stromal
lymphopoietin (TSLP) (right) mRNA expression levels were determined by quan-
titative reverse transcription-polymerase chain reaction (qRT-PCR). (B) ST2 cells
were plated at a density of 2105 cells/mL in 6-well culture plates and cultured for
24 h. Indicated doses of Wnt5a were added, and the cells were cultured for further
48 h. Total RNA was extracted from the cells, and IL-7 mRNA expression level was
determined by qRT-PCR. Data are presented as means7S.D. *, po0.05, **, po0.01.
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then the activation of noncanonical Wnt signaling in stromal cells
may affect B-lymphogenesis through the regulation of IL-7
expression.
3.2. IL-7 and CXCL12 expression are important for the maintenance
of B cells in a coculture system
To determine the ability of ST2 cells to maintain B cells in a
coculture system, mouse BM cells were cultured on layers of dif-
ferent adherent cells, such as MC3T3-E1, MLO-Y4, and ST2 cells
under inducible B-lymphogenesis condition. Among these ad-
herent cells only ST2 cells could support B cells, and after 4 days
we could detect B220-positive B cells among ﬂoating cells
(Fig. 2A). To evaluate whether ST2 cells were able to maintain B
cells during long-term coculture systems, number of ﬂoating cells
and of several types of hematopoietic cells, such as B220-positive
B cells, CD3ε-positive T cells and CD11b-positive myeloid cells
were examined. In this culture system, ST2 cells were able to
maintain B220-positive B cells for 7 days, but not CD3ε-positive T
cells and CD11b-positive myeloid cells (Fig. 2B). ST2 cells highly
expressed IL-7 and CXCL12 mRNA compared with other adherent
cells (Fig. 2C), indicating that IL-7 and CXCL12 expression in ST2
cells may be important for long-term B cell coculture systems.
3.3. Regulation of the ability of ST2 cells in supporting B cells bynoncanonical Wnt signaling
To examine whether the change in IL-7 and CXCL12 expression
in ST2 cells by noncanonical Wnt signaling affected the ability to
maintain B cells, we cultured mouse BM cells on the layer of ST2,
Wnt3a-ST2, or Wnt5a-ST2 cells. After 5 or 7 days of culture, we
analyzed the number of B220-positive IgM-negative B-cell pro-
genitors and of B220-positive B cells in ﬂoating hematopoietic
cells by ﬂow cytometry. The number of B220-positive IgM-nega-
tive B-cell progenitors cultured for 7 days on Wnt5a-ST2 cells
signiﬁcantly increased and also the number of progenitors cul-
tured on Wnt3a-ST2 cells slightly increased but not signiﬁcantly.
The percentage of B220-positive IgM-negative B-cell progenitors
cultured on both Wnt3a-and Wnt5a-ST2 cells were signiﬁcantly
increased (B220þ/IgM B cell progenitors on ST-2 cells;
42.2171.9%, Wnt3a-ST2 cells; 51.6071.7%, Wnt5a-ST2 cells;
55.1272.4%). This result indicated that also canonical Wnt sig-
naling in stromal cells may regulate B cell differentiation with or
without modulation of IL-7. On the other hand, the number of
B220-positive B cells cultured for 5 or 7 days on Wnt3a-ST2 cells
or Wnt5a-ST2 cells did not change (Fig. 3A). To elucidate whether
the activation of Wnt signaling modulated cell proliferation and
affected B-lymphogenesis, we performed a cell proliferation assay.
The number of vital Wnt3a-ST2 and Wnt5a-ST2 cells cultured for
3 days was not altered (Fig. 3B). These results suggest that Bcell
progenitors were maintained by noncanonical Wnt signaling in
stromal cells probably through the upregulation of IL-7 expression.4. Discussion
In the present study, noncanonical Wnt5a enhances IL-7 mRNA
expression in stromal cells. IL-7 is produced by stromal cells re-
siding in the primary and secondary lymphoid organs, and its
receptor (IL7R), consisting of an IL7Rα chain and a common γ
chain, is expressed in lymphoid cells and is critical for lympho-
genesis. IL-7– and IL-7Rα–deﬁcient mice show a block in early
B-cell development at the uncommitted B cell stage [16,17]. In
early B-cell development, it is generally thought that the IL7R and
the pre-B cell antigen receptor synergistically activate both the
MAPK/Erk and the PI3K signaling pathway, resulting in enhanced
cell proliferation and survival [3]. Our results suggest that the
noncanonical Wnt5a functionally enhances IL-7 production in ST2
cells and that IL-7 then regulates early Bcell expansion in a co-
culture system. Previous studies showed that IL-7 also plays a
critical role in T-cell development in primary and secondary lym-
phoid organs [25]. Regulation of IL-7 expression by noncanonical
Wnt signaling may contribute to not only B-cell but also T-cell
development.
Hematopoiesis is regulated by autocrine and paracrine me-
chanisms. Many Wnt family proteins are expressed in
hematopoietic tissues, and a series of reports suggest that they
have important roles in not only the maintenance of HSCs in the
niche but also in the development of hematopoietic cells, includ-
ing B cells [26]. Wnt signaling regulates B-lymphogenesis via both
cell intrinsic and cell extrinsic mechanisms in primary lymphoid
organs. A previous study reported that Wnt5a-deﬁcient mice
showed increased B cell proliferation [27]. However, this B-lym-
phogenetic abnormality was intrinsic to the hematopoietic cells,
since abnormality of Wnt5a/ hematopoietic cells could not be
rescued by transplantation of recipient mice whose BM stromal
cells expressed Wnt5a [27]. Our results using coculture systems
have the possibility that Wnt3a- or Wnt5a-transfected ST2 cells
secrete the Wnt proteins, thus regulating IL-7 expression and af-
fecting early B-lymphogenesis. Consistent with our results, Wnt5a
conditioned medium or Wnt5a overexpressing stromal cells also
N
um
be
r o
f B
22
0+
 c
el
ls
 (X
10
4 )
R
el
at
iv
e 
C
X
C
L1
2
m
R
N
A
 e
xp
re
ss
io
n
BM with - MC3T3
-E1
MLO
-Y4
ST2
MC3T3
-E1
MLO-
Y4
ST2
**
**
N
um
be
r o
f c
el
ls
 (X
10
4 )
7 days5 days
*
R
el
at
iv
e 
IL
-7
m
R
N
A
 e
xp
re
ss
io
n
MC3T3
-E1
MLO-
Y4
ST2
Fig. 2. ST2 cells maintained B cells in a coculture system. (A and B) Murine bone marrow (BM) cells were cultured with indicated cell lines for 4 days. Floating cells were
analyzed for B220, CD3ε, and CD11b expression by FACS. (C) Indicated cells were cultured to semiconﬂuence, and then total RNA was extracted. IL-7 (left) and CXCL12 (right)
mRNA expression levels were determined by qRT-PCR. Data are presented as means7S.D. *, po0.05.
M. Sato, M. Tamura / Biochemistry and Biophysics Reports 6 (2016) 179–184182enhanced early B cell development in coculture systems [10,11].
Taken together, these data indicate that B-lymphogenesis might be
regulated by noncanonical Wnt ligand through cell extrinsic me-
chanisms, such as regulation of IL-7 and CXCL12 expression in
stromal cells.
To elucidate the regulation of hematopoiesis through the BM
niche, niche cell compartment and identiﬁcation of factors derived
from niche cells are important because they regulate BM hema-
topoiesis. Two distinct niches have been identiﬁed in the BM: the
vascular niche and the osteoblastic niche. The vascular niche may
play important roles in regulating HSC mobilization and in re-
taining the cells in a quiescent state. Visnjic et al. showed that the
osteoblast ablation resulted in the alteration of hematopoiesis
[28]. Also, the deletion of CXCL12 from osterix positive stromal
cells or col2.3 positive osteoblasts resulted in the depletion of B
lymphocytes [29,30]. These studies suggest that the osteoblastic
niche may be composed by CXCL12-expressing stromal cells,
which include osteoblast precursors and support B lymphocyte
commitment and differentiation from HSC [29,30]. In this study,we used ST2 cells as stromal cells, and we showed that ST2 cells
could maintain hematopoietic cells in coculture system. ST2 cells
cultured with osteoblastic inducers, including ascorbic acid and
dexamethasone, exhibited characteristics typical of osteoblasts,
such as formation of mineralized nodules [31], thus indicating that
ST2 cells are similar to pre-osteoblasts [31]. Taken together, these
data indicate that ST2 cells are similar to osteoblastic niche cells
in vivo, thus suggesting that our in vitro culture studies on
B-lymphogenesis regulation through the change of IL-7 and
CXCL12 expression in ST2 cells by Wnt signaling may elucidate the
regulatory system in the B-lymphoid niche in vivo.
During hematopoiesis, several studies showed the inﬂuence of
Wnt signaling on niche cells in the BM. Osteoblastic niche cells
predominantly express noncanonical Wnt ligands such as Wnt5a
[32]. Also, Wnt signaling plays an important role in bone meta-
bolism by controlling differentiation of osteoblasts and osteoclasts.
One key implication of our data is that B-cell development is di-
rectly linked to the noncanonical Wnt signaling in the stromal
cells, indicating that noncanonical Wnt signaling in the BM might
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Fig. 3. Noncanonical Wnt signaling in ST2 cells regulates B-lymphogenesis. (A) Murine BM cells were cultured with the indicated cell lines for the indicated times. Floating cells
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M. Sato, M. Tamura / Biochemistry and Biophysics Reports 6 (2016) 179–184 183contribute to B-lymphogenesis partly through IL-7 expression.
Hardy et al. reported that B220 positive and IgM negative im-
mature B cells divided into three populations and they showed
phenotypic distinctions. Interestingly, cell proliferation of all of
immature B cell populations dependent on the presence of stromal
cells and two of populations response to IL-7. In another popula-
tion, less responsive to IL-7, of immature B cells, their proliferation
was absolutely depend on stromal cell contact and some cell
contact-mediating signals seem to be essential for survival [33].
Thus the role of IL-7 induced by noncanonical Wnt signaling in
stromal cells for B-lymphogenesis may be partial and other factors
including CXCL12 are also involved for B-lymphogenesis. Overall,our results suggest that the further characterization of the effects
of Wnt signaling in B-lymphogenesis through cell extrinsic me-
chanism will elucidate the local mechanisms regulating stem cell
lineage commitment and differentiation.Acknowledgements
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